The Children's Hospital of Philadelphia was awarded $38.9 million to advance gene‑editing therapies for hemophilia A and ...

Columnist Allyx Formalejo offers a meditation on the path toward finding balance in a relationship in the midst of difficult ...

Recognition of hemophilia in women and girls is better, but challenges remain in getting accurate diagnoses and proper care, ...

It can be easy to judge people whose illness is invisible, says columnist Cazandra Campos-MacDonald, but let's try to show empathy instead.

Columnist Jennifer Lynne shares how she addresses chronic pain and structural damage from her various bleeding disorders.

Early genetic testing done during IVF may be an option to help couples affected by hemophilia have healthy babies, a 10-year ...

Columnist Allyx Formalejo writes how living with her husband's hemophilia changed her relationship with the goals she had set ...

Factor VIII (FVIII) replacement therapy is a cornerstone of treatment for many people with hemophilia A, a rare bleeding disorder caused by deficient or dysfunctional FVIII, a protein needed for blood ...

Experimental treatment denecimig maintained low bleed rates in hemophilia A, with safety findings consistent with earlier ...

Artificial intelligence (AI) in healthcare? You’ve got to be kidding me! What a ridiculous idea! That sounds horrifying. We don’t want computers diagnosing us; we want trained, experienced ...

Jennifer Lynne is an entrepreneur specializing in digital marketing, a self-professed computer nerd, and a nationally competitive Scrabble player. Jennifer has strong ties to the bleeding disorder ...

Hemophilia is a blood disorder that is characterized by a shortage of specific clotting factors that help to form blood clots and stop bleeding. Historically, the primary treatment for hemophilia is ...